1BMM
HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-4-[(AMINOIMINOMETHYL)AMINO]-N-[[1-[3-HYDROXY-2-[(2-NAPHTHALENYLSULFONYL)AMINO]-1-OXOPROPYL]-2-PYRROLIDINYL] METHYL]BUTANAMIDE (BMS-186282)
Experimental procedure
Detector technology | AREA DETECTOR |
Collection date | 1993-06-15 |
Detector | SIEMENS-NICOLET X100 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 108.170, 81.220, 46.000 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 8.000 - 2.600 |
R-factor | 0.177 |
Rwork | 0.177 |
RMSD bond length | 0.013 |
RMSD bond angle | 1.580 * |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | X-PLOR (3.1) |
Refinement software | X-PLOR (3.1) |
Data quality characteristics
Overall | |
High resolution limit [Å] | 2.600 * |
Rmerge | 0.067 |
Total number of observations | 24598 * |
Number of reflections | 10811 * |
Completeness [%] | 75.6 * |
Redundancy | 2.27 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 7.3 * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | protein | 1.5-3 (mg/ml) | |
2 | 1 | drop | HEPES | 25-37.5 (mM) | |
3 | 1 | drop | 15 (mM) | ||
4 | 1 | drop | PEG8000 | 9-10 (%(w/v)) | |
5 | 1 | drop | sodium acetate | 20 (mM) | |
6 | 1 | drop | magnesium chloride | 5 (mM) | or lithium chloride |
7 | 1 | reservoir | PEG8000 | 18-20 (%(w/v)) | |
8 | 1 | reservoir | sodium acetate | 40 (mM) | |
9 | 1 | reservoir | magnesium chloride | 10 (mM) | or lithium chloride |